Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society.
In: Lymphatic Research & Biology, Jg. 20 (2022-10-01), Heft 5, S. 539-547
academicJournal
Zugriff:
Background: Secondary lymphedema mostly occurs as an aftereffect of cancer treatment, and it is estimated that 100,000–150,000 patients are affected in Japan. An estimated 3500 patients, develop lymphedema of the lower and upper extremities each year secondary to uterine and breast cancer treatment. Medical reimbursement was first instituted in April 2008 by the Ministry of Health, Labour and Welfare in Japan. Since 2008, we have developed guidelines regarding treatment options for patients with lymphedema based on scientific evidence. This is the third edition of the guidelines established by the Japanese Lymphedema Society (JLES), published in 2018. The JLES Practice Guideline-Making Committee (PGMC) developed 21 clinical questions (CQs). Methods and Results: A review of these 15 CQs was performed in accordance with the methodology for establishing clinical guidelines. The 15 recommendations for each of these CQs were developed and discussed until consensus by the PGMC was reached. Moreover, outside members who had no involvement in these guidelines evaluated the contents using the Appraisal of Guidelines for Research and Evaluation (AGREE) II reporting checklist. Conclusion: These guidelines have been produced for the adequate management of lymphedema by doctors and other medical staff on the lymphedema management team of medical institutes, including nurses, physical technicians, and occupational therapists. [ABSTRACT FROM AUTHOR]
Copyright of Lymphatic Research & Biology is the property of Mary Ann Liebert, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Evidence-Based Practice Guideline for the Management of Lymphedema Proposed by the Japanese Lymphedema Society.
|
---|---|
Autor/in / Beteiligte Person: | Kitamura, Kaoru ; Iwase, Satoru ; Komoike, Yoshifumi ; Ogawa, Yoshinari ; Utsugi, Kuniko ; Yamamoto, Daigo ; Odagiri, Hiroki |
Zeitschrift: | Lymphatic Research & Biology, Jg. 20 (2022-10-01), Heft 5, S. 539-547 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1539-6851 (print) |
DOI: | 10.1089/lrb.2021.0032 |
Sonstiges: |
|